Quinolones: from Bench to Bedside, ESCMID Postgraduate Education Course

5 - 7 October 2011, Santander, Spain


Luis Martínez-Martínez, Santander, ES, on behalf of the ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS)

Course Materials

Presentations are available for ESCMID members exclusively. Please log in or register.


Wednesday, 5 October 2011, 09:00 – 18:30


  • Mechanism of action of quinolones. Peter Heisig
  • Mechanisms of resistance to quinolones in Gram-positive bacteria. Emmanuelle Cambau
  • Mechanisms of resistance to quinolones in Gram-negative bacteria. José Manuel Rodríguez
  • Mechanisms of plasmid-mediated quinolone resistance. Alvaro Pascual
  • Epidemiology of plasmid-mediated quinolone resistance. Alessandra Carattoli

Practical cases of interpretative reading and clinical impact of the antibiogram. Dora Szabo and Jesús Rodríguez-Baño


Thursday, 6 October 2011, 09:00 – 18:30


  • Epidemiology of chromosomally encoded quinolone resistance. Gian Maria Rossolini
  • Virulence factors in quinolone-resistant organisms. Jordi Vila
  • Pharmaco-kinetic and pharmaco-dynamic aspects of quinolones. Federico Pea

    Presentation not available

  • Breakpoints for clinical categorisation of quinolone activity. Rafael Cantón

    Presentation not available

Practical cases of interpretative reading and clinical impact of the antibiogram. Luis Martínez-Martínez and Jesús Rodríguez-Baño

Presentation not available


Friday, 7 October 2011, 9:00 – 17:00


  • Phenotypic and genotypic methods for detection of quinolone resistance. Christian Giske
  • Evaluation of quinolone activity with animal models. Jerónimo Pachón
  • Clinical impact of quinolone resistance. Bruno Fantin
  • Quinolones for therapy of mycobacterial infections. Alexandra Aubry
  • Clinical use of quinolones. M. Carmen Fariñas
Course Faculty
  • Alexandra Aubry, Paris, FR
  • Emmanuelle Cambau, Paris, FR
  • Rafael Cantón, Madrid, ES
  • Alessandra Carattoli, Rome, IT
  • Giuseppe Cornaglia, Verona, IT
  • Bruno Fantin, Paris, FR
  • M. Carmen Fariñas, Santander, ES
  • Christian Giske, Stockholm, SE
  • Peter Heisig, Bonn, DE
  • Luis Martínez-Martínez, Santander, ES
  • Jerónimo Pachón, Seville, ES
  • Alvaro Pascual, Seville, ES
  • Federico Pea, Udine, IT
  • José Manuel Rodríguez, Seville, ES
  • Jesús Rodríguez Baño, Seville, ES
  • Gian Maria Rossolini, Siena, IT
  • Dora Szabo, Budapest, HU
  • Jordi Vila, Barcelona, ES
Contact Person (Education Programme)

Luis Martínez-Martínez, Santander, ES


Administrative Secretariat

Marta de Isla Álvarez

AFID Congresos S.L.
Menéndez Pelayo, 6 Ent. A
39006 Santander

Phone +34 942 318180
Fax +34 942 318653

Course Objectives
  • To explain the clinical relevance of microbiological laboratory data for quinolones.
  • To analyse the mechanisms of action and of resistance to this group of antimicrobial agents and their relationship with bacterial virulence.
  • To discuss the influence of these issues and of PK/PD parameters in defining clinical categories along with their impact on the clinical use of these agents.
  • To present practical cases of quinolone use in the clinical setting, with an interactive discussion moderated by both a clinical microbiologist and an infectious disease specialist.
Course Venue

Continuing Education Facilities
Pabellón 16
University Hospital Marqués de Valdecilla
Avda. Valdecilla s/n
Santander, Spain

Target Audience

30 – 45 clinical microbiologists, clinical pharmacologists or infectious disease specialists interested in the study and/or the clinical use of quinolones.